Navigation Links
Elaborate Network Drives When and Where Proteins Are Made
Date:10/28/2008

Study finds molecules convey genetic instructions from nuclei to fulfill different roles

TUESDAY, Oct. 28 (HealthDay News) -- What proteins a cell makes when and where appears to be influenced by an extensive network of regulatory interactions, say researchers at the Stanford University School of Medicine.

The new research, done on yeast, concludes that certain proteins guide molecules carrying genetic instructions from a cell's nuclei to many other locations within the cell where the instructions are carried out.

The findings were published Oct. 27 in Public Library of Science -- Biology.

Proteins are the main structural components of living cells, doing most of the cell's work. They must be produced in an orderly way to fulfill the many different roles they play at different times. The question, though, has been: How do they accomplish so many various things, when virtually all of an organism's cells contain the same genes?

"If you gaze into the genome, you see lots of regions that don't code for proteins but are conserved in nature -- they remain unchanged from organism to organism over eons of evolutionary time," investigator Dan Hogan, a graduate student at the university's medical school, said in a news release issued by the school. "This suggests that these regions may be playing some important regulatory role."

The researchers found a system of regulation instigated by a class of proteins that binds to RNA. These guide the fate of most, if not all, protein-coding RNA molecules. The study showed that virtually every protein-coding RNA molecule encoded in the yeast genome appears to be bound by specific combinations of RNA-binding proteins (RBPs). These are directed to their target RNAs by short, barcode-like sequences on those RNA molecules. The team has already found more than 500 different RBPs in yeast.

"Our work suggests that what had seemed like a relatively few s
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. MITEM Releases Blue Iris eLaborate 8.6
2. Caring.com Launches First Ad Network to Reach Family Caregivers
3. Agito Networks Customer Selected to Present at the Mobile Enterprise Executive Summit 2008 Conference
4. The HealthCentral Network Names Jeremy Shane President and Chief Operating Officer
5. Intent.com Launches Premier Wellness Site & Social Network
6. Autism Support Network Launches, Offers Free Online Support Community
7. Autism Support Network Launches, Offers Free Online Support Community
8. NFL Network Tackles Youth Fitness With New National Initiative to Keep Gym in School
9. Consumers Life Expands Healthcare Network in Northeast Indiana
10. Mens Health Network Welcomes its Newest Member to its Nationwide Team, The Sean Kimerling Testicular Cancer Foundation
11. From the Web to human diseases, UH talk uncovers network similarities

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Elaborate Network Drives When and Where Proteins Are Made
Elaborate Network Drives When and Where Proteins Are Made
(Date:12/1/2009)...RESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNewswire/ ...2001 and have expanded over the years serving the ...cility which was originally set up in an area of 2...ices, as part of the suite of services by Max Neem...s a valuable offering. ,, The pharmacy inventor...
(Date:12/1/2009)...SHINGTON, Dec. 1 Indivi...more likely than those with traditional coverage t... be more engaged in wellness programs, and to be m...tter in holding down costs, according to survey re...enefit Research Institute (EBRI). ,, At the sa...
(Date:12/1/2009)...ORT LAUDERDALE, Fla., Dec. 1 Orbus...rollment in the randomized clinical trial of the C... Stent). ,, A prospective, randomized, multicen...of an ablu M inal sirolimus coat ED bio- E ...p to 20 sites in Asia, Australia, Europe and South...
(Date:12/1/2009)...ients in California are unable to successfully obt...hospitals despite recent state legislation intende...w study. , Posing as low-income uninsured patien... than one-third of the hospitals they approached a...han those allowed under California law, according ...
(Date:12/1/2009)... Lumension announces general availabilit...e to deliver end-to-end endpoint management capabi... management console architecture. , ... -- Lumension, a global leader in endpoint managem...n® Endpoint Management and Security Suite (LEM...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6
... Children,s Hospital UCLA have found that low-dose...the overall quality of life for adolescents suffer...he syndrome affects 6 percent of middle school stu... is the first of its kind to look at the effects o...
... In times of economic,uncertainty, engaging emplo...same time, becomes much more challenging. Engaged ...nization that employs them and that, in,turn, tran...ts into activities that drive employee engagement ...
...cial Guidance for Fiscal 2008 through 2010, PITTS...oday that it will host a conference call and live ...provide a review of the first,quarter ended March ...rck Generics, which the company acquired on,Oct. 2...
... A brand leader notes, "We make,decisions for the...." Brand,decisions must be made at the right time,...ximize the value of a brand., Brand Management ha...ore -- but that is fraught with potential,pitfalls...
...Illinois Residents to Say it out loud, CHICAGO, M...is residents is experiencing a mental health chall...ign was launched today to promote,good mental heal...lt in Illinois, lower the barriers that prevent pe...
...ION, WASHINGTON, May 1 The following media,advis...er(s):, Peter I. Buerhaus, PhD, RN, FAAN, Profess...inary Health Workforce Studies, Vanderbilt,Univers...th Ulrich, EdD, RN, FACHE, FAAN, Senior Vice Presi...
Other Medicine News:Health News:Antidepressant found to alleviate symptoms of irritable bowel syndrome in adolescents 2Health News:Complimentary Excerpt of Employee Engagement: Programs and Activities that Work Available from Best Practices 2Health News:Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008 2Health News:Best Practices in Designing Effective Brand Teams 2Health News:Making It Easier to Talk About Mental Health 2Health News:Making It Easier to Talk About Mental Health 3Health News:Making It Easier to Talk About Mental Health 4Health News:Will Nursing Shortage Cripple Future Health Care Plans? 2
(Date:12/1/2009)..., , TAI,AN, China, Dec. 1 /PR...s, Inc. (OTC Bulletin Board: CBPO) (Nasdaq: CBPO ... leading plasma-based biopharmaceutical companies ...eived approval to list its,common stock on the NAS...ts its shares to begin trading on the NASDAQ on,We...
(Date:12/1/2009)..., , BEIJING, Dec. 1 /PRNewswire...eading provider of biopharmaceutical products in C...rth purchase order for its H1N1 vaccine, PANFLU.1(...tion Technology for the national,purchase plan. Un...oduce an,additional one million doses of PANFLU.1 ...
(Date:12/1/2009)..., , ROCKVILLE, Md., Dec. 1 /PRNewswire-Fi...NDA ) announced today that the waiting period has ...t Improvements Act of 1976 with respect to Vanda,s...Pharma AG, and that the agreement is now effective...ting effectiveness of the agreement, triggers an u...
Breaking Medicine Technology:China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Light at the speed of a bicycle and much more 56500 1Light at the speed of a bicycle and much more 56500 2Sinapis Pharma Announces Frederick Frank as Consultant 56499 1Sinapis Pharma Announces Frederick Frank as Consultant 56499 2Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 1Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 2
...rum Institut (SSI) and Intercell, report promisi...h a tuberculosis (TB) subunit vaccine , , »...ains Intercell’s,adjuvant IC31™ , , ...y the European Union aims to,either , repla...uo;Calmette vaccine” or,to , boost it...
... 15, 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) to...n a novel nucleotide analog, GS 9219, which has sh...l studies, at the,2007 Annual Meeting of the Ameri...will take place in Los Angeles on April 14-18, 200...ly focused on,oncology, GS 9219 emerged from our e...
Other Medicine Technology:Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 2Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 3Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 4Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219,to be Presented at AACR 2Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219,to be Presented at AACR 3
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: